ConMed accedes to the demands of a major shareholder, appointing a new chairman to replace founder Eugene Corasanti, who will leave the board entirely this year.
ConMed (NSDQ:CNMD) reached a deal with an institutional investor that owns a 6% stake in the medical device company that will see founder Eugene Corasanti step down as chairman, effective immediately.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1kisHku
Cap comentari:
Publica un comentari a l'entrada